MAIA Biotechnology Inc. Financial Flexibility Index
MAIA Biotechnology Inc. financial flexibility index. MAIA Biotechnology Inc. (MAIA) has a Financial Flexibility Index of -0.70x as of March 2026. Free cash flow of $-5.31 Million (operating CF $-5.31 Million minus capex $0.00) represents -1% of total liabilities ($7.56 Million).
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of MAIA Biotechnology Inc. (2019–2025)
Financial flexibility index of MAIA Biotechnology Inc. from 2019 to 2025. Historical Financial Flexibility Index trend for MAIA Biotechnology Inc. across 7 annual periods. Explore MAIA cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
MAIA Biotechnology Inc. Financial Flexibility Index by Year (2019–2025)
MAIA Biotechnology Inc. financial flexibility index by year from 2019 to 2025. Year-by-year free cash flow to debt coverage for MAIA Biotechnology Inc.. For the full cash flow conversion analysis, see cash efficiency ratio of MAIA Biotechnology Inc..
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -2.57x | $-18.84 Million | $-18.84 Million | $7.33 Million | ▼ -6.8% |
| 2024 | -2.41x | $-15.70 Million | $-15.70 Million | $6.52 Million | ▼ -30.6% |
| 2023 | -1.84x | $-13.07 Million | $-13.07 Million | $7.09 Million | ▲ +46.4% |
| 2022 | -3.44x | $-12.10 Million | $-12.10 Million | $3.51 Million | ▼ -79.2% |
| 2021 | -1.92x | $-4.12 Million | $-4.12 Million | $2.15 Million | ▼ -146.2% |
| 2020 | -0.78x | $-1.84 Million | $-1.84 Million | $2.36 Million | ▲ +79.6% |
| 2019 | -3.82x | $-1.57 Million | $-1.57 Million | $409.74K | — |